Milligan John C.K. IV 4
4 · TherapeuticsMD, Inc. · Filed May 12, 2021
Insider Transaction Report
Form 4
Milligan John C.K. IV
DirectorPresident, Secretary, Director10% Owner
Transactions
- Sale
Common Stock
2021-05-11$1.04/sh−44,252$46,022→ 1,752,703 total - Exercise/Conversion
Restricted Stock Units
2021-05-10−103,500→ 207,000 totalExercise: $0.00→ Common Stock (103,500 underlying) - Exercise/Conversion
Common Stock
2021-05-10+103,500→ 1,796,955 total
Holdings
- 3,582,373(indirect: See Footnote)
Common Stock
Footnotes (5)
- [F1]On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
- [F2]The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- [F3]Shares are owned by John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.
- [F4]Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
- [F5]The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.